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Abstract
Mechanical circulatory support - either ventricular assist device (VAD, left-sided systemic 
support) or cavopulmonary assist device (CPAD, right-sided support) - has been suggested as 
treatment for Fontan failure. The selection of left- vs. right-sided support for failing Fontan has not 
been previously defined.
Computer simulation and mock circulation models of pediatric Fontan patients (15–25 kg) with 
diastolic, systolic, and combined systolic and diastolic dysfunction were developed. The global 
circulatory response to assisted Fontan flow using VAD (HeartWare HVAD, FL) support, CPAD 
(Viscous Impeller Pump, IN) support, and combined VAD and CPAD support were evaluated.
Cavopulmonary assist improves failing Fontan circulation during diastolic dysfunction but 
preserved systolic function. In the presence of systolic dysfunction and elevated ventricular end-
diastolic pressure (VEDP), VAD support augments cardiac output and diminishes VEDP, while 
increased preload with cavopulmonary assist may worsen circulatory status.
Fontan circulation can be stabilized to biventricular values with modest cavopulmonary assist 
during diastolic dysfunction. Systemic VAD support may be preferable to maintain systemic 
output during systolic dysfunction. Both systemic and cavopulmonary support may provide best 
outcome during combined systolic and diastolic dysfunction. These findings may be useful to 
guide clinical cavopulmonary assist strategies in failing Fontan circulations.
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Introduction
Despite medical and surgical advances, Fontan palliation of single ventricle birth defects 
remains problematic for a significant number of patients, leading to Fontan failure [1]. 
Patients with failing Fontan circulations have been implanted with a ventricular assist device 
(VAD) as a bridge to transplant [2,3]. Although systemic VAD support unloads the native 
ventricle, diminishing ventricular volume and external work, and augmenting the 
myocardial supply-demand ratio, its use in Fontan may not be ideal. In a Fontan circulation, 
preload is often insufficient and pathophysiology predominates on the right side of the 
circulation. While there have been reports of successful bridge to transplantation using VAD 
support in failing Fontan patients for brief periods of time, the results reported for post-
cardiotomy bridge to transplantation have been poor [4]. Significantly, pediatric bridge to 
transplant support of failing Fontan patients with a VAD is usually not successful.
A concerted effort is currently underway to develop cavopulmonary assist devices (CPAD) 
to power the Fontan circulation by delivering a modest pressure boost (2–5 mmHg) at the 
level of the total cavopulmonary connection (TCPC) [5–9]. Support considerations include 
two microaxial pumps in the vena cava(e) [5] or a single percutaneous pump which can 
augment Fontan flow in all 4 axes of the TCPC without risk of venous pathway obstruction 
[6–8]. Once a safe and reliable device becomes available, it will be possible to provide high-
volume, low-pressure flow augmentation similar to normal right ventricular hemodynamics 
to alleviate the sequelae of elevated systemic venous pressure and low cardiac output. In a 
univentricular Fontan circulation, CPAD support will simultaneously decrease systemic 
venous pressure and increase ventricular preload. It would restore physiologic status to one 
more closely resembling more stable 2-ventricle physiology, in essence enabling clinical 
management of the patient as a “biventricular Fontan” [1].
A key question to address prior to clinical application of mechanical circulatory support is 
how the single ventricle will respond to increased preload with CPAD support or reduced 
ventricular pressures and volumes with VAD support in the setting of longstanding systolic 
and/or diastolic dysfunction. A long-term follow up of Fontan survivors found preserved 
systolic function in 73% of subjects and diastolic dysfunction in 72% of patients [10,11]. 
Diastolic dysfunction is the predominant pathophysiologic feature in Fontan patients and is 
presumably secondary to: 1) prior staged repair in which a volume load was imposed on the 
ventricle; and 2) chronic preload deprivation and impaired ventricular filling. Thus, we 
hypothesize that a majority of patients with failing Fontan circulations will respond 
favorably to an increase in preload from cavopulmonary assist by increased cardiac output.
The circulatory response to VAD or CPAD support in the presence of systolic vs. diastolic 
dysfunction is undefined. Animal models of Fontan do not exist, making it a challenge to 
precisely define the circulatory response to cavopulmonary assist prior to clinical 
application. In this study, in silico and in vitro mock circulatory modeling were used to 
assess the circulatory response to VAD and cavopulmonary assist with respect to systolic 
and diastolic ventricular dysfunction. Based on the findings, an objective algorithm to guide 
clinical application of cavopulmonary assist is proposed.
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Methods
Computer Simulation Model
A previously reported computer simulation model of the pediatric (~15–25 kg) single 
ventricle Fontan physiology was used in this study [7]. This Fontan model was developed 
from a biventricular computer simulation model that has been used in previous studies to 
develop and test physiologic control algorithms for mechanical circulatory support devices 
[12–15]. Briefly, the computer model subdivides the Fontan circulatory system into 2 heart 
valves and 9 blocks, which include common atrium, single ventricle, pulmonary and 
systemic circulations, vena cava, aorta, and coronary circulation. The volume of blood in 
each block is described by a differential equation as a function of volume (V), pressure (P), 
compliance (C), and resistance (R), which is an expression for the macrosopic material 
balance for the block given by:
where dVn/dt is the rate of change of volume in block n, Fin is the blood flow rate into the 
block, and Fout is the blood flow rate out of the block.
The heart rate, resistances, and compliances of the Fontan model were modified to 
reproduce hemodynamic pressure and flow waveforms of the univentricular Fontan 
physiology of a 4 year old with (i) diastolic dysfunction with normal pulmonary resistance 
(NPR), (ii) diastolic dysfunction with elevated pulmonary resistance (Right/pulmonay side 
failure, RSF), (iii) systolic dysfunction due to diminished ventricular contractility and 
normal pulmonary resistance (left/systemic side failure, LSF), and (iv) combined systolic 
and diastolic dysfunction due to diminished ventricular contractility and elevated pulmonary 
resistance (left and right sided failure, LRSF) were developed based on literature [10,16–18] 
and clinical guidance. Specifically, RSF was simulated by increased pulmonary arterial and 
venous resistances, which resulted in reduced preload and venous return. LSF single 
ventricle Fontan circulation was modeled by adjusting the time-varying compliance curve of 
the single ventricle block to diminish ventricular contractility to simulate systolic 
dysfunction. LRSF single ventricle Fontan circulation was modeled via integration of 
increased pulmonary resistances from RSF and altered ventricular time-varying compliance 
curve from LSF.
Models of a VAD and/or CPAD were integrated into the computer simulation models of 
univentricular Fontan circulation. Simulations were conducted to predict acute 
hemodynamic responses including coronary flows, ventricular pressure-volume loops, 
ventricular external work, arterial pressures, and vascular pulsatility parameters for VAD 
and CPAD flow ranging from 0L/min (no support) to 3.25 L/min (full support). Ventricular, 
aortic, and cavopulmonary pressures, aortic, coronary, and cavopulmonary flows, and 
ventricular volume and external work were calculated.
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In-vitro mock circulatory loop modelling
A mock circulation system consisting of a silicone ventricle, aorta, systemic and pulmonic 
resistances and compliances, and a cavopulmonary junction was used to simulate the 
univentricular Fontan circulation (Figure 1) [7]. The cavopulmonary junction is rigid with 
11 mm diameter SVC and IVC and 9mm diameter pulmonary arteries that are connected to 
flexible silicone tubing. The clinically approved ventricular assist device (HeartWare 
HVAD, Miami Lakes, FL) inlet was attached to the single ventricle apex and the outlet 
cannula was attached to the proximal aorta. A CPAD (Viscous Impeller Pump, Indianapolis, 
IN) that is currently under development was placed in the cavopulmonary junction. Aortic, 
pulmonary arterial, and VAD flows were measured using Transonic Flow Probes (Transonic 
Systems, Ithica, NY). Aortic (proximal and distal), atrial, vena caval, and pulmonary arterial 
pressures were measured using single tipped pressure catheters (Millar Instruments, TX). 
The single ventricle pressure and volume were measured using a pressure-volume 
conductance catheter (Millar Instruments, TX). Ventricular driveline pressure, heart rate, 
systemic and pulmonary resistances and compliances were adjusted to reproduce 
hemodynamic waveforms of univentricular Fontan physiology of a 4-year old with (i) 
diastolic dysfunction with normal pulmonary resistance (NPR), (ii) diastolic dysfunction 
with elevated pulmonary resistance (RSF), (iii) systolic dysfunction due to diminished 
ventricular contractility and normal pulmonary resistance (LSF), and (iv) combined systolic 
and diastolic dysfunction due to diminished ventricular contractility and elevated pulmonary 
resistance (LRSF). RSF was simulated by increasing pulmonary resistance, which resulted 
in diminished preload and venous return. LSF single ventricle Fontan circulation was 
modeled by reducing the driveline pressure of the pneumatic driver to diminish ventricular 
contractility to simulate systolic dysfunction. LRSF single ventricle Fontan circulation was 
modeled by increasing pulmonary resistance and reducing ventricular driveline pressure. 
Baseline hemodynamic pressure and flow data were collected for the univentricular Fontan 
circulation (no VIP or VAD support). Hemodynamic data were obtained for partial (1.7±0.2 
L/min) and full (3.2±0.3 L/min) VIP and/or VAD support with the VIP/VAD rpm adjusted 
to match the desired flow rate.
Results
Fontan circulation with diastolic dysfunction (NPR)
The unsupported Fontan circulation, even with normal pulmonary resistance, had elevated 
cavopulmonary pressure and diminished preload, cardiac output, aortic systolic and diastolic 
pressures compared to normal biventricular circulation [12], indicating diastolic dysfunction. 
CPAD support increased cardiac output, ventricular end-diastolic pressures and volumes, 
and aortic systolic and diastolic pressures and volumes (Table 1,Figure 2A,3A). CPAD 
support restored cardiac output, ventricular end-diastolic pressures, and aortic systolic and 
diastolic pressures to normal biventricular circulation values. Significantly, the restoration of 
hemodynamic parameters of the Fontan circulation to near normal values was achieved with 
only modest shift of pressure head (~5 mmHg) in the cavopulmonary junction. VAD support 
diminished ventricular external work and increased cardiac output. Importantly, ventricular 
end diastolic pressure and volumes were significantly diminished beyond nominal values 
indicating an increased risk of suction (Figure 2A,3A). Combined CPAD and VAD support 
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augmented ventricular systolic pressures but end-diastolic pressures and volumes were not 
augmented significantly from full VAD support values.
Fontan circulation with diastolic dysfunction and elevated pulmonary resistance (RSF)
Elevated pulmonary resistance resulted in significantly increased cavopulmonary pressure 
and diminished preload, cardiac output, aortic systolic and diastolic pressures compared to 
Fontan circulation with normal pulmonary resistance, Figure 2 B. CPAD support augmented 
cardiac output, ventricular end-diastolic pressures and volumes, and aortic systolic and 
diastolic pressures and volumes (Table 1,Figure 2B,3B). VAD support diminished 
ventricular external work and increased cardiac output. However, VAD support resulted in 
negative ventricular end diastolic pressures, which is a strong indication of suction (Figure 
2A,3A). Combined CPAD and VAD support augmented ventricular systolic pressures but 
end-diastolic pressures and volumes were not augmented significantly from complete VAD 
support values.
Fontan circulation with systolic dysfunction (LSF)
Systolic dysfunction resulted in significantly increased preload and ventricular end diastolic 
pressures, and diminished cardiac output, aortic systolic and diastolic pressures compared to 
Fontan circulation with normal pulmonary resistance, Figure 2 C. The cardiac outputs of 
Fontan circulations with RSF and LSF were similar. VAD support diminished ventricular 
end diastolic pressure and preload to nominal values while augmenting cardiac output 
(Table 1,Figure 2C,3C). CPAD support augmented ventricular external work and increased 
ventricular end-diastolic pressures and volumes beyond normal values (Figure 2C,3C). 
Combined CPAD and VAD support diminished ventricular end-diastolic pressures and 
volumes compared to CPAD support values. However, the ventricular end diastolic 
pressures were still higher than the normal range.
Fontan circulation with systolic and diastolic dysfunction (LRSF)
Fontan circulation with systolic and diastolic dysfunction results in significantly diminished 
cardiac outputs compared to NPR, LSF and RSF, Table 1. VAD support caused ventricular 
suction while CPAD support increased ventricular end diastolic pressure above nominal 
values. Combined CPAD and VAD support resulted in diminished ventricular work, 
pressures and volumes. Importantly, combined CPAD and VAD support resulted in 
ventricular end diastolic pressures in the normal range.
DISCUSSION
Over the past 30 years, an increasing cohort of survivors of Fontan palliation of functional 
single ventricle is emerging with many of these patients expected to eventually present with 
clinical Fontan failure. The Fontan patient cohort has several subgroups with different 
etiologies and underlying causes for Fontan failure. Fontan failure is typically not the same 
as systemic ventricular failure with systolic dysfunction. A long-term follow up of Fontan 
survivors found preserved systolic function in 73% of subjects and diastolic dysfunction in 
72% of patients [10,11]. The clinical manifestations of Fontan failure may be more 
representative of decompensated systemic venous sequelae of Fontan physiology rather than 
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that of primary ventricular failure. Stated more clearly, primary myogenic failure is not the 
underlying precipitating problem.
Currently, the therapeutic options for failing Fontan patients are limited to medical therapy, 
surgical optimization of passive Fontan flow, and mechanical circulatory support therapy. 
Medical therapy is of modest value, and only represents secondary therapy. Diuretic therapy 
may reduce the sequelae of increased tissue water, but at the expense of circulating blood 
volume, which is essential to maintenance of cardiac output and circulatory homeostasis. 
Inotrope therapy may increase ventricular contractility, but in a ventricle with insufficient 
preload, the magnitude of this benefit may be suboptimal. Phosphodiesterase inhibitors may 
have benefit on long-term functional status in prospective randomized trials, although the 
magnitude of this benefit is not yet clear [19]. To overcome the limitations of medical 
therapy, surgical approaches to passively optimize TCPC to reduce power losses by perhaps 
1–2 mmHg have been proposed [20]. In this region of the circulation, an incrementally small 
improvement in hemodynamic efficiency may have tangible benefits. This is supported 
clinically by patients who undergo Fontan conversion from an atriopulmonary to a TCPC 
type of construction. However, surgical modifications of the TCPC have yet to be applied 
clinically on a significant scale. A very late surgical option is transplantation, which has 
issues and concerns of its own, and does not currently represent a long-term ideal option. 
For the forthcoming patients expected to present with Fontan failure, the lack of a primary 
therapy is increasingly a subject of urgency and concern.
Mechanical systemic circulatory support with VAD has been described for patients with 
failing Fontan circulation [2,3]. Systemic VAD support of Fontan can provide a reliable 
source of systemic flow, but it does not address the right-sided circulatory deficiencies 
typically inherent in Fontan circulation– namely coexisting systemic venous pressure 
elevation and reduced preload. To address this issue directly, a right-sided circulatory 
support device specifically designed to address these problems would be required. At 
present, a low-pressure device ideally suited to provide the 5–10 mmHg pressure necessary 
for transpulmonary blood flow is not commercially available. Applying contemporary VAD 
or total artificial heart (TAH) technologies to the right-sided Fontan circulation requires the 
take down of the Fontan connection to ensure effective right-sided flow [21]. The TCPC is 
an open venous channel, and there is no means to accomplish inflow and outflow 
cannulation in an unaltered TCPC without recirculation and lack of forward flow. Certainly, 
takedown of a Fontan connection and placement of bi-VADs or TAH is not a trivial 
consideration. TAH implantation also requires the creation of a receptacle for systemic 
venous return complicating surgical complexity and risk. Further, the device (VAD or TAH) 
becomes the sole, obligate path for right-sided cardiac output. If the device fails for any 
reason, it is a potentially lethal problem. Current MCS technologies are optimally designed 
to provide systemic support, and cannot address the unique needs of Fontan cavopulmonary 
support. For these reasons, the existing options to apply commercially available VAD 
support in a failing Fontan circulation are extremely limited and are associated with poor 
outcomes [4]. Emerging concepts in cavopulmonary assist devices (CPAD), however, may 
change this treatment paradigm by specifically addressing the right-sided circulatory support 
needs in a Fontan circulation [5–9].
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A key question to address prior to clinical application of mechanical circulatory support in 
Fontan patients is how the single ventricle will respond to increased preload with CPAD 
support or reduced ventricular pressures and volumes with VAD support in the setting of 
longstanding systolic and/or diastolic dysfunction. The results of this study demonstrate that 
cavopulmonary assist improves failing Fontan circulation in the setting of diastolic 
dysfunction but preserved systolic function by augmenting cardiac output and increasing the 
preload to the single ventricle. Systemic VAD support is contraindicated for patients with 
diastolic dysfunction as it will further diminish preload and ventricular end diastolic 
pressure to unacceptably low levels which may precipitate ventricular suction. In the 
presence of systolic dysfunction and elevated ventricular end diastolic pressures, systemic 
VAD support augments cardiac output and diminishes ventricular end diastolic pressures. 
Increased preload with cavopulmonary assist may worsen circulatory status by significantly 
increasing the ventricular preload, volume, and end diastolic pressure. Inotropic support may 
offset the increased preload with cavopulmonary support to a certain extent. In cases of 
mixed systolic and diastolic dysfunction, both systemic and cavopulmonary support may 
provide the best outcome. Based on these findings, a mechanical circulatory support 
treatment algorithm for Fontan patients is presented in Figure 4. This algorithm is based on 
traditionally measured parameters for Fontan patients including ventricular end diastolic 
pressure, cardiac index, and pulmonary resistance. Pivotal to the selection of right-sided vs 
left-sided support is the underlying contractile status of the single ventricle.
Limitations
Chronic animal models of univentricular Fontan circulation that accurately replicate Fontan 
hemodynamics do not exist, making it a challenge to test the circulatory response to 
ventricular or cavopulmonary assist prior to clinical application. Computer simulation and 
mock circulation of the Fontan circulation is representative of clinical observations from a 
purely hemodynamic viewpoint, and is not intended to replace the importance and 
significance of in vivo models. While incapable of replicating all expected clinical 
conditions and responses, in-silico and in-vitro modeling does provide a controlled 
environment to test the effects of VAD and CPAD support and potential failure modes, 
which is valuable in device development and is not possible in vivo. As examples, the 
models do not simulate diastolic dysfunction due to restrictive atrioventricular valve. 
Systemic support with atrial cannulation will more likely to provide successful support in 
this condition. Additionally, diastolic dysfunction due to changes in end-systolic pressure 
volume relationship or isovolumetric relaxation time were not simulated. The computer 
simulation model does not account for the 2 mmHg respiratory variation in systemic venous 
pressure. Ventricular contractility and heart rate were kept constant to reduce experimental 
variability. Physiologically, heart rate and the contractility will increase with increasing 
preload in accordance with the Frank-Starling mechanism. The mock circulation system has 
mechanical valves which may create large aortic valve pressure gradients and ringing during 
valve closure. The computer simulation model does not account for viscosity changes or 
inertial effects while the length of tubing in the mock circulation may cause added inertial 
effects. However, the inertial effects represent less than 2% of the total power. Inertance 
mismatch or small viscosity changes would not affect the results significantly, as 
demonstrated by the similarity in results between the computer simulation and mock 
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circulation models. Despite these limitations, this study enabled the development of 
treatment algorithm using mechanical circulatory support devices for Fontan failure. These 
findings may be useful to guide clinical decision-making strategies for mechanical assist in 
patients with failing Fontan circulations in the future as Fontan-specific mechanical 
circulatory support devices come into clinical use.
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Figure 1. 
Pediatric Fontan mock circulatory system with: (1) Single ventricle, (2) Aorta, (3) Arterial 
Compliance, (4) Systemic vascular resistance, (5) venous compliance, (6) Fontan junction 
with cavopulmonary assist device (VIP), (7) Pulmonary resistance, (8) Pulmonary 
compliance, and (9) ventricular assist device.
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Figure 2. 
Single ventricular pressure (SVP), aortic pressure (AoP), vena caval pressure (VCP), and 
pulmonary arterial vasculature pressure (PAP) during (i) no support, (ii) full VAD support, 
(iii) full CPAD support, and (iv) full VAD and CPAD in Fontan circulations with (A) 
normal pulmonary resistance (NPR), (B) diastolic dysfunction with elevated pulmonary 
resistance (Right/pulmonic side failure, RSF), (C) systolic dysfunction (left/systemic side 
failure, LSF), and (D) combined systolic and diastolic dysfunction (left and right side 
failure, LRSF). (E) Sample waveforms generated from computer simulation and mock 
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circulation demonstrate similar aortic pressures. The ringing in the aortic pressure 
waveforms are due to the tilting disc valve used in the mock circulation.
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Figure 3. 
Single ventricular pressure –volumes loops during no support, full VAD support, full CPAD 
support, and full VAD and CPAD support conditions in Fontan circulations with (A) normal 
pulmonary resistance (NPR), (B) diastolic dysfunction with elevated pulmonary resistance 
(Right/pulmonic side failure, RSF), (C) systolic dysfunction (left/systemic side failure, 
LSF), and (D) combined systolic and diastolic dysfunction (left and right side failure, 
LRSF).
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Figure 4. 
Algorithm for mechanical circulatory support for patients with non-restrictive Fontan 
failure.
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